19 June 2013
Keywords: new, chairman, glaxosmithkline, tadataka, yamada, resign, post
Article | 13 February 2006
Tadataka Yamada, will resign from the post of chairman, R&D and executive director of GlaxoSmithKline, the world's second largest
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 February 2006
© 2013 thepharmaletter.com